{
    "id": 27212,
    "cites": 49,
    "cited_by": 0,
    "reference": [
        "Institute of Medicine (IOM), The Public Health Emergency Medical Countermeasures Enterprise: Innovative Strategies to Enhance Products from Discovery Through Appoval, Workshop Summary (National Academies Press (US), Washington, DC, 2010; https://www.ncbi.nlm.nih.gov/books/NBK50754/).",
        "Office of the Assistant Secretary for Preparedness and Response, Project BioShield Annual Report: January 2014\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u0090December 2014 (2014).",
        "S. A. Lister, Pandemic Influenza: Appropriations for Public Health Preparedness and Response (2007; https://fas.org/sgp/crs/misc/RS22576.pdf).",
        "EBOLA Vaccine (Solicitation #17-100-SOL-00013)FedBizOpps.gov (2017) (available at https://www.fbo.gov/index?s=opportunity&mode=form&id=8ef263bed8bf48653ae6b6825c 15052a&tab=core&_cview=1).",
        "J. C. Larsen, G. L. Disbrow, Project BioShield and the Biomedical Advanced Research Development Authority: A 10-Year Progress Report on Meeting US Preparedness Objectives for Threat Agents, Clin. Infect. Dis. 64, 1430\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1434 (2017).",
        "HHS Press Office, HHS accelerates development of first Ebola vaccines and drugs (2017) (available at https://www.hhs.gov/about/news/2017/09/29/hhs-accelerates-developmentfirst -ebola-vaccines-and-drugs.html).",
        "R. Glennerster, M. R. Kremer, A Better Way to Spur Medical Research and Development, Regulation 23, 34\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c39 (2000).",
        "A. S. Kesselheim, Drug Development for Neglected Diseases \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d The Trouble with FDA Review Vouchers, N. Engl. J. Med. 359, 1981\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1983 (2008).",
        "T. J. Hwang, A. S. Kesselheim, Vaccine Pipeline Has Grown During The Past Two Decades With More Early-Stage Trials From Small And Medium-Size Companies., Health Aff. 35, 219\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 26 (2016). May 2020  2020 by Vu, Kaplan, Chaudhuri, Mansoura, Lo All Rights Reserved Page 16 of 19",
        "R. Levine, M. Kremer, A. Albright, Making Markets for Vaccines: Ideas to Action (2005; https://www.cgdev.org/doc/books/vaccine/MakingMarkets-complete.pdf).",
        "D. B. Ridley, H. G. Grabowski, J. L. Moe, Developing drugs for developing countries., Health Aff. 25, 313\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c324 (2006).",
        "J. H. Rex, K. Outterson, Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach, Lancet Infect. Dis. 16, 500\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c505 (2016).",
        "K. Outterson, U. Gopinathan, C. Clift, A. D. So, C. M. Morel, J. A. R??ttingen, Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality, PLoS Med. 13, e1002043 (2016).",
        "U.S. House of Representatives, H.R.6 \u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u0090 21st Century Cures Act (U.S. House of Representatives, 114th Congress, 2015; https://www.congress.gov/bill/114thcongress /house-bill/6).",
        "A. Gaffney, M. Mezher, Z. Brennan, Regulatory explainer: everything you need to know about FDA\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s priority review vouchers (2017) (available at http://www.raps.org/RegulatoryFocus /News/2015/07/02/21722/Regulatory-Explainer-Everything-You-Need-to-KnowAbout -FDA\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s-Priority-Review-Vouchers/).",
        "J. Berman, T. Radhakrishna, The Tropical Disease Priority Review Voucher: A GameChanger for Tropical Disease Products., Am. J. Trop. Med. Hyg. 96, 11\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c13 (2017).",
        "D. B. Ridley, A. C. Sanchez, Introduction of European priority review vouchers to encourage development of new medicines for neglected diseases., Lancet 376, 922\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c927 (2010).",
        "F. Gottron, The Project BioShield Act: Issues for the 113th Congress (2014; https://fas.org/sgp/crs/terror/R43607.pdf).",
        "P. Sands, C. Mundaca-Shah, V. J. Dzau, The Neglected Dimension of Global Security--A Framework for Countering Infectious-Disease Crises, N. Engl. J. Med. 374, 1281\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1287 (2016).",
        "V. Y. Fan, D. T. Jamison, L. H. Summers, The Inclusive Cost of Pandemic Influenza Risk (2016; http://www.nber.org/papers/w22137).",
        "World Health Organization, Warning signals from the volatile world of influenza viruses (2015) (available at http://www.who.int/influenza/publications/warningsignals201502/en/).",
        "Center for Infectious Disease Research and Policy (CIDRAP), World Bank says flu pandemic could cost $3 trillion | CIDRAP (2008) (available at http://www.cidrap.umn.edu/news-perspective/2008/10/world-bank-says-flu-pandemiccould -cost-3-trillion).",
        "V. Colizza, A. Barrat, M. Barthelemy, A. J. Valleron, A. Vespignani, Modeling the worldwide May 2020  2020 by Vu, Kaplan, Chaudhuri, Mansoura, Lo All Rights Reserved Page 17 of 19 spread of pandemic influenza: Baseline case and containment interventions, PLoS Med. 4, 0095\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c0110 (2007).",
        "N. M. Ferguson, D. A. T. Cummings, C. Fraser, J. C. Cajka, P. C. Cooley, D. S. Burke, Strategies for mitigating an influenza pandemic, Nature 442, 448\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c452 (2006).",
        "D. Gouglas, T. Thanh Le, K. Henderson, A. Kaloudis, T. Danielsen, N. C. Hammersland, J. M. Robinson, P. M. Heaton, J.-A. R\u00c3\u0083\u00c2\u00b8ttingen, Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study., Lancet. Glob. Heal. 6, e1386\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009ce1396 (2018).",
        "World Health Organization, List of Blueprint priority diseases (2017) (available at http://www.who.int/blueprint/priority-diseases/en/).",
        "A. W. Lo, C. Ho, J. Cummings, K. S. Kosik, Parallel discovery of Alzheimer\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s therapeutics., Sci. Transl. Med. 6, 241cm5 (2014).",
        "H. Qi, D. Sun, A Quadratically Convergent Newton Method for Computing the Nearest Correlation Matrix, SIAM J. Matrix Anal. Appl. 28, 360\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c385 (2006).",
        "World Bank launches \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093pandemic bond\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d to tackle major outbreaksReuters (2017) (available at https://www.reuters.com/article/us-global-pandemic-insuranceidUSKBN19J2JJ) .",
        "AIR Worldwide Expands Its Global Pandemic ModelNasdaq GlobeNewswire (2016) (available at https://globenewswire.com/newsrelease /2016/07/25/858573/10164236/en/AIR-Worldwide-Expands-Its-Global-PandemicModel. html).",
        "World Health Organization, Dengue Control: Chikungunya (2017) (available at http://www.who.int/denguecontrol/arbo-viral/other_arboviral_chikungunya/en/).",
        "S. Chusri, P. Siripaitoon, K. Silpapojakul, T. Hortiwakul, B. Charernmak, P. Chinnawirotpisan, A. Nisalak, B. Thaisomboonsuk, C. Klungthong, R. V Gibbons, R. G. Jarman, Kinetics of Chikungunya Infections during an Outbreak in Southern Thailand, 2008-2009, Am. J. Trop. Med. Hyg. 90, 410\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c417 (2014).",
        "Centers for Disease Control and Prevention, Chikungunya outbreak progresses in Caribbean, Central and South America (2014) (available at https://www.cdc.gov/media/releases/2014/p1106-chikungunya-outbreak.html).",
        "Pan American Health Organization, Number of reported cases of Chikungunya Fever in the Americas--Cumulative Cases, 2015 (2016) (available at http://www.paho.org/hq/index.php?option=com_docman&task=doc_download&Itemid=270 May 2020  2020 by Vu, Kaplan, Chaudhuri, Mansoura, Lo All Rights Reserved Page 18 of 19 &gid=33091&lang=en).",
        "Pan American Health Organization, Number of reported cases of Chikungunya Fever in the Americas in 2016 (2017) (available at http://www.paho.org/hq/index.php?option=com_docman&task=doc_download&Itemid=270 &gid=37867&lang=en).",
        "D. G. McNeil Jr., Saudi Arabia: MERS Toll RevisedNew York Times , A6 (2014).",
        "World Health Organization, Middle East respiratory syndrome coronavirus (MERS-CoV) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c Republic of Korea (2015) (available at http://www.who.int/csr/don/03-july-2015-merskorea /en/).",
        "Center for Disease Control and Prevention, Chronology of Marburg Hemorrhagic Fever Outbreaks (2014) (available at https://www.cdc.gov/vhf/marburg/resources/outbreaktable. html).",
        "M. O. Nanyingi, P. Munyua, S. G. Kiama, G. M. Muchemi, S. M. Thumbi, A. O. Bitek, B. Bett, R. M. Muriithi, M. K. Njenga, A systematic review of Rift Valley Fever epidemiology 1931-2014., Infect. Ecol. Epidemiol. 5 (2015), doi:10.3402/iee.v5.28024.",
        "O. Ogbu, E. Ajuluchukwu, C. J. Uneke, Lassa fever in West African sub-region: an overview, J. Vector Borne Dis. 44, 1\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c11 (2007).",
        "M. K. Kindhauser, T. Allen, V. Frank, R. Santhana, C. Dye, Zika: the origin and spread of a mosquito-borne virus, Bull. World Health Organ. (2016), doi:http://dx.doi.org/10.2471/BLT.16.171082.",
        "World Health Organization, Zika Situation Report (2016; http://www.who.int/emergencies/zika-virus/situation-report/who-zika-situation-report12 -02-2016.pdf).",
        "M. E. J. Woolhouse, L. Brierley, C. McCaffery, S. Lycett, Assessing the Epidemic Potential of RNA and DNA Viruses., Emerg. Infect. Dis. 22, 2037\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2044 (2016).",
        "A. Gluck, Letter to Tim Murphy, Diana DeGette (2017) (available at http://docs.house.gov/meetings/IF/IF02/20170523/106020/HHRG-115-IF02-20170523SD009. pdf).",
        "J. Berlinger, Ebola vaccine gives 100% protection, study findsCNN.com (2016) (available at http://www.cnn.com/2016/12/22/health/ebola-vaccine-study/index.html).",
        "Centers for Disease Control and Prevention, CDC\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Ongoing Work to Contain Ebola in West Africa (2016; https://www.cdc.gov/vhf/ebola/pdf/cdcs-ongoing-work.pdf).",
        "Centers for Disease Control and Prevention, CDC Vaccine Price List (January 3, 2017) (2017) (available at https://www.cdc.gov/vaccines/programs/vfc/awardees/vaccinemanagement /price-list/2017/2017-01-03.html).",
        "UNICEF, Product Menu for Vaccines Supplied by UNICEF for Gavi, the Vaccine Alliance (2015) (available at https://www.unicef.org/supply/files/Product_Menu_31_March_2015.pdf).",
        "Pan American Health Organization, Expanded Program of Immunization Vaccine Prices for Year 2016World Heal. Organ. Reg. Off. Am. , 2016 (2016)."
    ]
}